RANKINGS
Key list: leading companies in Europe by R&D expenditure
Powered by
This month our pharma industry key list brings you the 15 leading companies in Europe by R&D expenditure, as ranked by GlobalData's Pharma Intelligence Centre. All numbers up to date as of June 2021.
| Company name | Headquarters location | No. of employees | R&D expenditure ($M) |
F. Hoffmann-La Roche Ltd | Switzerland | 101,465 | 11,768 |
Novartis AG | Switzerland | 110,000 | 8,386 |
Sanofi | France | 99,412 | 7,098 |
Bayer AG | Germany | 99,329 | 5,981 |
GlaxoSmithKline Plc | UK | 94,066 | 5,537 |
AstraZeneca Plc | UK | 76,100 | 5,320 |
Merck KGaA | Germany | 57,850 | 2,501 |
Novo Nordisk AS | Denmark | 45,157 | 2,021 |
UCB SA | Belgium | 8,409 | 1,424 |
Viatris Inc | US | 45,000 | 519 |
H. Lundbeck AS | Denmark | 5,628 | 456 |
Ipsen SA | France | 5,703 | 435 |
Jazz Pharmaceuticals Plc | Ireland | 1,940 | 410 |
Mallinckrodt Plc | Ireland | 3,100 | 349 |
Grifols SA | Spain | 23,668 | 284 |
